Abceutics

Abceutics

Unverified
At Abceutics Inc, our comprehensive technological solutions help enhance Antibody-Drug Conjugates in the treatment of cancer to improve patient outcomes.

Market cap
-
Net debt
-
Enterprise valuation
$208m (Public information from Apr 2024)
Buffalo New York (HQ)
  • Edit
DateInvestorsAmountRound
*

$208m

Valuation: $208m

Acquisition
Total Funding000k

Recent News about Abceutics

Edit